News Focus
News Focus
Followers 1742
Posts 144059
Boards Moderated 3
Alias Born 09/11/2005

Re: AppreciateThePenny post# 35

Saturday, 08/18/2012 9:34:39 AM

Saturday, August 18, 2012 9:34:39 AM

Post# of 1510
ELTP .106-Elite Pharmaceuticals is about to get FDA approval on 3 more pharmaceuticals to sell on the USA prescription drug market. They announced in their conference call after the earnings release, the FDA has completed the final inspection of the manufacturing facilities, so any day now, we expect more drug launches. The value proposition I see in a .10 stock that is not only FDA Good Manufacturing rated, but DEA Certified to make controlled substances.

They already have amphetamine diet pills (Phentermine), Generic Dilaudid (Hydromorphone), and Methadone on the USA market, all launched within the past year.

The value of a DEA approved manufacturing facility is not priced into the stock, imo, at .10.

So when ELTP has 3 more drugs on the market and still a full pipeline of other products to launch, will the stock price still be .10? I doubt it.

Here's a link to ELTP's launched and waiting for approval products for verification..

http://www.elitepharma.com/product_pipeline.asp

GLTA

BTW- got the board marked

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today